Company: SABR
Filing Date: 2025-03-13
Form Type: DEF 14A
Source: 0001193125-25-053907
Chunk: 37

Company: Sabre Corp
Filing Date: 2025-03-13
Form: DEF 14A
Chunk 37
---
 the participant, and may be exercised by these transferees during the lifetime of the participant, but only to the extent the transfers are permitted by the Committee. Change in Control Except as otherwise set forth in a participant’s award agreement, in the event (i) a participant has a qualifying termination of employment following a change in control of Sabre or (ii) of a change in control of Sabre in which outstanding awards are not assumed, continued, or substituted by the surviving corporation:

| • |     | All deferral of settlement, forfeiture conditions, and other restrictions applicable to awards granted under the 2025 Omnibus Plan will lapse, and such awards will be deemed fully vested as of the time of the change-in-control transaction without regard to deferral and vesting conditions, and |

| • |     | Any award carrying a right to exercise that was not previously exercisable and vested will become fully exercisable and vested as of the time of the change in control of Sabre. |

For purposes of this provision, a “qualifying termination of employment” means with respect to a participant, (i) a termination of such participant’s employment by Sabre, the surviving corporation (or any of Sabre’s or the surviving corporation’s then-affiliated entities) without cause or by the participant for good reason (as such terms are defined in the 2025 Omnibus Plan), or (ii) a termination of such participant’s employment in the event of the participant’s death or disability, in each case, following a change in control of Sabre.

| Sabre Corporation 2025 Proxy Statement |     | | |     | 45 |

| PROPOSAL 3: APPROVAL OF THE SABRE CORPORATION 2025 OMNIBUS INCENTIVE COMPENSATION PLAN |

New Plan Benefits All awards made under the 2025 Omnibus Plan are discretionary. Therefore, the benefits and amounts that will be received or allocated under the 2025 Omnibus Plan are not determinable at this time. The closing price of our common stock, as reported on the Nasdaq Stock Market, on February 28, 2025 was $4.13 per share. See “Executive Compensation—2024 Grants of Plan-Based Awards,” which provides information on the equity awards granted to the named executive officers in 2024. U.S. Federal Income Tax Consequences The following is a summary of certain federal income tax consequences of the awards to be made under the 2025 Omnibus Plan based upon the laws in